BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23933312)

  • 1. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
    Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB; Gratton A
    Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens.
    Ragnauth A; Znamensky V; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 877(1):65-72. PubMed ID: 10980244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
    Ragnauth A; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
    MacDonald AF; Billington CJ; Levine AS
    Brain Res; 2004 Aug; 1018(1):78-85. PubMed ID: 15262208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues.
    Guy EG; Choi E; Pratt WE
    Behav Brain Res; 2011 Jun; 219(2):265-72. PubMed ID: 21262268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaba(A) receptors in the pedunculopontine tegmental nucleus play a crucial role in rat shell-specific dopamine-mediated, but not shell-specific acetylcholine-mediated, turning behaviour.
    Ikeda H; Akiyama G; Matsuzaki S; Sato M; Koshikawa N; Cools AR
    Neuroscience; 2004; 125(3):553-62. PubMed ID: 15099669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen.
    Noble F; Cox BM
    J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA; Kalivas PW
    J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intersite GABA receptor subtype antagonist effects upon mu opioid receptor agonist-induced feeding elicited from either the ventral tegmental area or nucleus accumbens shell in rats.
    Ackerman TF; Lamonte N; Bodnar RJ
    Physiol Behav; 2003 Jul; 79(2):191-8. PubMed ID: 12834790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine receptor effects on accumbal shell dopamine-mediated turning behaviour in rats.
    Moribe S; Ikeda H; Sato M; Akiyama G; Matsuzaki S; Hasegawa K; Koshikawa N; Cools AR
    Neuropharmacology; 2005 Sep; 49(4):514-24. PubMed ID: 15935407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.